A randomized clinical trial of immunization with combined hepatitis A and B versus hepatitis B alone for hepatitis B seroprotection in hemodialysis patients

American Journal of Kidney Diseases

Volumn 56, Issue 4, 2010, Pages 713-719

  Tung, Jennifer ^a   Carlisle, Euan ^b   Smieja, Marek ^b   Kim, Peter T ^c   Lee, Christine H ^b  

^a MCMASTER UNIVERSITY   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

^c UNIVERSITY OF GUELPH   (Canada)

Author keywords

hemodialysis; hepatitis B seroprotection; Hepatitis B vaccine

Indexed keywords

ANTIBODY; HEPATITIS A HEPATITIS B VACCINE; HEPATITIS B ANTIGEN; IMMUNOSUPPRESSIVE AGENT; PREDNISONE; RAPAMYCIN; RECOMBINANT HEPATITIS B VACCINE; HEPATITIS A VACCINE; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; VACCINE;

ADULT; AGED; ANTIBODY BLOOD LEVEL; ANTIBODY TITER; ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FEVER; FLU LIKE SYNDROME; HEMODIALYSIS PATIENT; HEPATITIS A VIRUS; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; IMMUNIZATION; IMMUNOGENICITY; INFECTION PREVENTION; INJECTION SITE PAIN; INJECTION SITE SWELLING; LETHARGY; MAJOR CLINICAL STUDY; MALE; NAUSEA; OUTCOME ASSESSMENT; PAIN; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SEROCONVERSION; SKIN BRUISING; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE; VIRUS DETECTION; COMPARATIVE STUDY; FOLLOW UP; IMMUNOLOGY; INTRAMUSCULAR DRUG ADMINISTRATION; KIDNEY FAILURE, CHRONIC; MIDDLE AGED; PRIMARY PREVENTION; PROCEDURES; REFERENCE VALUE; RENAL REPLACEMENT THERAPY; RISK ASSESSMENT; VERY ELDERLY;

AGED; AGED, 80 AND OVER; FEMALE; FOLLOW-UP STUDIES; HEPATITIS A VACCINES; HEPATITIS B; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VACCINES; HUMANS; IMMUNIZATION; IMMUNIZATION SCHEDULE; INJECTIONS, INTRAMUSCULAR; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PRIMARY PREVENTION; PROSPECTIVE STUDIES; REFERENCE VALUES; RENAL DIALYSIS; RISK ASSESSMENT; TREATMENT OUTCOME; VACCINES, COMBINED;

EID: 77956919791     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2010.04.015     Document Type: Article

References (30)

1. D.L. Murdoch, K. Goa, and D.P. Figgitt Combined hepatitis A and B vaccines: a review of their immunogenicity and tolerability Drugs 63 23 2003 2625 2649
2. M. Sherman, V. Bain, and J.P. Villeneuve The management of chronic viral hepatitis: a Canadian consensus conference 2004 Can J Gastroenterol 18 12 2004 715 728 (Pubitemid 40103639)
3. J. Zhang, S. Zou, and A. Giulivi Hepatitis B in Canada Canada Communicable Disease Report 2001 Sept 10 12 27S3
4. D. Daniels, S. Grytdal, A. Wasley Centers for Disease Control and Prevention (CDC) Surveillance for acute viral hepatitisUnited States, 2007 MMWR Surveill Summ 58 3 2009 1 27
5. Hepatitis B Vaccine Canadian Immunization Guide 2007 Public Health Agency of Canada Infectious Disease and Emergency Preparedness Branch Centre for Infectious Disease Prevention and Control under the authority of the Minister of Public Works and Government Services Canada Ottawa, Ontario
6. M.C. Rangel, V.G. Coronado, G.L. Euler, and R.A. Strikas Vaccine recommendations for patients on chronic dialysis Semin Dial 13 2 2000 101 107
7. C.E. Stevens, H.J. Alter, P.E. Taylor, E.A. Zang, E.J. Harley, and W. Szmuness Hepatitis B vaccine in patients receiving hemodialysis Immunogenicity and efficacy N Engl J Med 311 8 1984 496 501
8. Recommendations for preventing transmission of infections among chronic hemodialysis patients MMWR Recomm Rep 50 RR-5 2001 1 43
9. M. Bock, E. Barros, and F.J. Veronese Hepatitis B vaccination in haemodialysis patients: a randomized clinical trial Nephrology (Carlton) 14 3 2009 267 272
10. K.M. Chow, M.C. Law, C.B. Leung, C.C. Szeto, and P.K. Li Antibody response to hepatitis B vaccine in end-stage renal disease patients Nephron Clin Pract 103 3 2006 c89 c93
11. N.K. Tong, J. Beran, and S.A. Kee Immunogenicity and safety of an adjuvanted hepatitis B vaccine in pre-hemodialysis and hemodialysis patients Kidney Int 68 5 2005 2298 2303 (Pubitemid 43117807)
12. N.C. Kong, J. Beran, and S.A. Kee A new adjuvant improves the immune response to hepatitis B vaccine in hemodialysis patients Kidney Int 73 7 2008 856 862
13. J.M. Mauri, and M. Valls Effects of recombinant interleukin-2 and revaccination for hepatitis B in previously vaccinated, non-responder, chronic uraemic patients Collaborative Group of Girona Nephrol Dial Transplant 12 4 1997 729 732
14. C. Ozener, A.S. Fak, E. Avar, S. Cinar, R. Lawrence, and E. Akolu The effect of alpha interferon therapy and short-interval intradermal administration on response to hepatitis B vaccine in haemodialysis patients Nephrol Dial Transplant 14 5 1999 1339 1340
15. M.E. Miquilena-Colina, T. Lozano-Rodrguez, and L. Garca-Pozo Recombinant interferon-alpha2b improves immune response to hepatitis B vaccination in haemodialysis patients: results of a randomised clinical trial Vaccine 27 41 2009 5654 5660
16. S. Sali, S.M. Alavian, and B. Hajarizadeh Effect of levamisole supplementation on hepatitis B virus vaccination response in hemodialysis patients Nephrology (Carlton) 13 5 2008 376 379
17. R. Prez-Garca, A. Prez-Garca, D. Verbeelen, E.D. Bernstein, V.G. Villarrubia, and M. Alvarez-Mon AM3 (Inmunofern) as an adjuvant to hepatitis B vaccination in hemodialysis patients Kidney Int 61 5 2002 1845 1852
18. K.A. Barraclough, K.J. Wiggins, and C.M. Hawley Intradermal versus intramuscular hepatitis B vaccination in hemodialysis patients: a prospective open-label randomized controlled trial in nonresponders to primary vaccination Am J Kidney Dis 54 1 2009 95 103
19. E.H. Fleischmann, J. Kruppenbacher, H.L. Bock, and M. Weber Active immunization against hepatitis A in dialysis patients Nephrol Dial Transplant 17 10 2002 1825 1828
20. F. Ambrosch, G. Wiedermann, and F.E. Andre Clinical and immunological investigation of a new combined hepatitis A and hepatitis B vaccine J Med Virol 44 4 1994 452 456
21. A. Knoll, B. Hottentrager, J. Kainz, and B.Jilg W. Bretschneider Immunogenicity of a combined hepatitis A and B vaccine in healthy young adults Vaccine 18 19 2000 2029 2032
22. G. Leroux-Roels, W. Moreau, I. Desombere, and A. Safary Safety and immunogenicity of a combined hepatitis A and hepatitis B vaccine in young healthy adults Scand J Gastroenterol 31 10 1996 1027 1031
23. P.A. Czeschinski, N. Binding, and U. Witting Hepatitis A and hepatitis B vaccinations: immunogenicity of combined vaccine and of simultaneously or separately applied single vaccines Vaccine 18 11-12 2000 1074 1080
24. B. Abraham, Y. Baine, and N. De-Clercq Magnitude and quality of antibody response to a combination hepatitis A and hepatitis B vaccine Antiviral Res 53 2002 63 73
25. National Advisory Committee on Immunization Canadian Immunization Guide 6th ed. 2002 Canadian Medical Association Ottawa, Ontario, Canada
26. Engerix-B product monograph July 28, 2005 GlaxoSmithKline
27. E. Pesanti Immunologic defects and vaccination in patients with chronic renal failure Infect Dis Clin North Am 15 3 2001 813 832
28. S. Sezer, F.N. Ozdemir, and G. Gz Factors influencing response to hepatitis B virus vaccination in hemodialysis patients Transplant Proc 32 2000 607 608
29. Hepatitis B (HBV) vaccines Abx Guide http://www.hopkins-abxguide.org/ Accessed April 23, 2008
30. G.H. Mayor, A.M. Klein, T.J. Kelly, and M.J. Patterson Antibody to hepatitis A and hemodialysis Am J Epidemiol 116 5 1982 821 827